LAZARD ASSET MANAGEMENT LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 21 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$10,946,000
-0.1%
10,037,0000.0%0.01%0.0%
Q2 2021$10,959,000
-27.3%
10,037,000
-28.3%
0.01%
-33.3%
Q1 2021$15,082,000
-7.1%
14,000,000
-6.7%
0.02%
-14.3%
Q4 2020$16,233,000
-18.3%
15,000,000
-21.6%
0.02%
-25.0%
Q3 2020$19,874,000
-1.8%
19,125,000
-0.6%
0.03%
-9.7%
Q2 2020$20,228,000
+19.0%
19,236,000
+20.2%
0.03%0.0%
Q1 2020$16,998,000
-9.5%
16,000,0000.0%0.03%
+14.8%
Q4 2019$18,783,000
+25.0%
16,000,000
+6.7%
0.03%
+8.0%
Q3 2019$15,028,000
+84.7%
15,000,000
+114.3%
0.02%
+78.6%
Q4 2017$8,137,000
-45.4%
7,000,000
-44.0%
0.01%
-48.1%
Q3 2017$14,914,000
-23.6%
12,500,000
-14.0%
0.03%
-27.0%
Q2 2017$19,516,000
-0.6%
14,531,000
-7.6%
0.04%0.0%
Q1 2017$19,634,000
+8.6%
15,731,0000.0%0.04%0.0%
Q4 2016$18,080,000
+31.4%
15,731,000
+36.8%
0.04%
+37.0%
Q3 2016$13,764,00011,500,0000.03%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Mohican Financial Management, LLC 2,000,000$2,431,0004.67%
LINDEN ADVISORS LP 83,156,000$99,022,0003.51%
SSI INVESTMENT MANAGEMENT LLC 7,831,000$9,301,0000.79%
TENOR CAPITAL MANAGEMENT Co., L.P. 7,500,000$8,975,0000.70%
CAPSTONE INVESTMENT ADVISORS, LLC 15,000,000$17,896,0000.63%
CSS LLC/IL 8,280,000$9,866,0000.48%
Castle Creek Arbitrage, LLC 4,000,000$4,762,0000.48%
WOLVERINE ASSET MANAGEMENT LLC 35,968,000$42,764,0000.47%
DAFNA Capital Management LLC 573,000$682,0000.42%
Polar Asset Management Partners Inc. 15,000,000$17,857,0000.36%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders